Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Jun 25, 2025 8:00 am EDT

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting

Jun 9, 2025 8:00 am EDT

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development

May 15, 2025 8:00 am EDT

OPKO Health to Participate in Two Upcoming Investor Conferences

Apr 30, 2025 4:05 pm EDT

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results

Apr 17, 2025 8:00 am EDT

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025

Apr 4, 2025 8:00 am EDT

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

Mar 17, 2025 8:00 am EDT

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

Mar 11, 2025 9:00 am EDT

Labcorp Announces Acquisition of Select Assets of BioReference Health’s Innovative Oncology and Related Clinical Testing Services Businesses

Feb 27, 2025 4:10 pm EST

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

Feb 13, 2025 4:05 pm EST

OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025